What to Know & Frequently Asked Questions

As ALS ONE becomes part of the ALS Network, we want to ensure our community, partners, and stakeholders have clear, transparent information about what this integration means and what to expect. The following information provides additional context about how this next step strengthens research, expands access to care, and builds on the shared mission and longstanding commitments of both organizations. This document is intended to address common questions and offer a deeper understanding of how the integration supports a stronger, more connected future for the ALS community.

What to Know:

ALS ONE is integrating into the ALS Network to accelerate research, expand care and advance technology that improves outcomes for people living with ALS.
The strategic integration combines ALS ONE’s Massachusetts research and care partnerships with the ALS Network’s global research, national care, and locally led patient services and related operational scale.
This is a mission-driven integration. Both organizations share the same urgency to advance care and cures for ALS as quickly as possible.
Research funding will increase through expanded corporate engagement, national scale, and deeper collaboration across institutions.
Technology will play a larger role in patient care, access to clinical trials, data sharing and research acceleration, supported by corporate leadership and expertise from the Salesforce network.
ALS ONE’s long-standing commitment to Massachusetts research institutions and care partners will remain a priority.
The integration allows both organizations to reduce duplication, increase efficiency, and direct more resources toward patient care and research.
People living with ALS and their families will see expanded corporate funding for research as well as increased access to clinical trials and care resources through technology advancements.
Leadership continuity is built into the integration. Mark Sullivan and Scott Gosnell will serve in governance roles to ensure ALS ONE’s mission remains central. Michael Braun will serve as an ALS Network Advisory Trustee.
The integration will occur in phases throughout 2026, pending the necessary state and federal processes.

Frequently Asked Questions:

Why is ALS ONE integrating into the ALS Network?

What does this integration mean for people living with ALS and their families?

Will ALS ONE’s Massachusetts research and care partners continue to be supported?

How will this improve ALS research?

What role does technology play in this integration?

Will current programs and services change?

Who will lead the integrated organization?

When will the integration be complete?

Why now?

How can donors and partners get involved?

What will happen to the ALS ONE license plate program?

Will ALS ONE continue grassroots fundraising and local events?

Signature events such as the Falmouth Road Race Team and Select Marathon Race Programs will continue and be bolstered through local participation and corporate partnerships. Opportunities to support ALS ONE and the ALS Network from wherever you are include the ALS Network’s Create a Fundraiser option and/or participating in events like our Endure to Cure ALS and Walk and Roll to Cure ALS events.